Summary of Bill HR 9157
Bill 118 HR 9157, also known as the Access to Pediatric Technologies Act of 2024, aims to improve access to innovative medical technologies for children. The bill recognizes the unique needs of pediatric patients and seeks to address the challenges they face in accessing cutting-edge treatments.
One key provision of the bill is the establishment of a Pediatric Device Consortium, which will bring together experts in pediatric medicine, industry representatives, and regulatory agencies to facilitate the development and approval of medical devices specifically designed for children. This consortium will work to streamline the regulatory process for pediatric devices, making it easier for manufacturers to bring new technologies to market.
Additionally, the bill includes provisions to incentivize the development of pediatric medical devices, such as grants and tax credits for companies that invest in pediatric research and development. These incentives are intended to encourage innovation in the field of pediatric medicine and ensure that children have access to the latest advancements in healthcare.
Overall, the Access to Pediatric Technologies Act of 2024 is aimed at improving the quality of care for pediatric patients by increasing access to innovative medical technologies. By addressing the unique needs of children and incentivizing the development of pediatric devices, this bill has the potential to make a significant impact on the health and well-being of young patients across the country.